Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Seasonal Allergic Rhinitis

In brief

Allergic rhinitis (AR) is a non-infectious chronic inflammatory disease of the nasal mucosa mainly mediated by immunoglobulin E after exposure to allergens in atopic individuals. The typical symptoms of AR are paroxysmal sneezing, watery rhinorrhea, itching, and nasal congestion, which may be accompanied by ocular symptoms, including eye itching, tearing, redness, and burning sensation, which are more common in patients with hay fever allergies. Bronchial asthma is associated with bronchial asthma in 40% of patients with AR, suggesting a comorbid feature of allergic disease.

Key facts

Study ID

NCT06300203

Run by

Beijing Tongren Hospital

People needed

120

Starts

2024-03-18

Expected to finish

2026-06-30

Last updated by the study team

2025-09-25

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Voluntarily sign the informed consent form.

You may not qualify if…

• Have any condition that are not suitable for participating in this study.

Where it is running

• Beijing Tongren Hospital, Capital Medical University — Beijing, Beijing Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.